Skip to content

EMBO study

EMBO study: Endometriosis meets Pelvic Floor - EMBO study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON57683
Enrollment
80
Registered
2025-04-01
Start date
2025-08-26
Completion date
Unknown
Last updated
2026-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometriosis Endometriosis

Interventions

During the visits, the participants are asked to fill out questionnaires about their: •? &nbsp
?Demographics and medical history (only first visit),&nbsp
•? &nbsp
?Endometriosis complaints (Endometriosis Health Profile–30 (EHP-30), during both visits),&nbsp
?Pelvic floor function (Pelvic Floor Disability index-20 (PFDI-20), during both visits)&nbsp
?Effect of the treatment (Patient Global Impression of Improvement (PGI-I), only last visit).&nbsp
During the two study visits, pelvic floor muscle function will be measured by 4D transperineal ultrasonographic strain measurements, and electromyography (EMG) measurements&nbsp

Sponsors

Ziekenhuis Groep Twente (ZGT)
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: Planned for hormonal endometriosis treatment, this includes both:Patients without previous hormonal treatmentPatients with previous hormonal treatment, but now change to different typeType of hormonal treatment will be loggedAble to read and understand Dutch languageSigned informed consent form

Exclusion criteria

Exclusion criteria: Under 18Active pelvic floor muscle therapy up to 6 months before study participationActive planned pelvic floor muscle therapy during study participationHistory of endometriosis surgery within the last 18 months or actively planned endometriosis surgery during study participation

Design outcomes

Primary

MeasureTime frame
The correlation between effectiveness of endometriosis treatment (EHP-30 score) and pelvic floor muscle function measured by direct functional measurements (functional ultrasound (strain) and EMG).

Secondary

MeasureTime frame
•?  ?The pelvic floor muscle function in women with endometriosis •?  ?The potential change in pelvic floor muscle function after hormonal endometriosis treatment •?  ?The correlation between different pelvic floor muscle function measures in the endometriosis population •?  ?The symptomatic improvement after hormonal endometriosis treatment

Countries

Netherlands

Contacts

Public ContactA Steen

Ziekenhuis Groep Twente (ZGT)

a.vsteen@zgt.nl0887085234

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Mar 20, 2026